Morepen Laboratories logo

Morepen Laboratories results

NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap

Last close ₹123.54up ₹5.87 (4.99%)BSE ₹123.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹117.67.

52-week range of traded prices to 23 Oct 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
Market cap
₹6,769 Cr1,108th largest listed
P/E
48.2
P/E without one-offs
59.0
P/B
5.4
Dividend yield
0.16%
ROE
11.7%
ROE without one-offs
9.5%
ROCE
10.3%
Debt to equity
0.16
Volume, NSE
50,63,581

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Morepen Laboratories annual results and balance sheet

Revenue
₹570 Cr+34.1% on a year ago · +17.6% on the quarter before
Operating profit
₹83 Cr+241.5% on a year ago · +237.6% on the quarter before
Net profit
₹56 Cr+424.7% on a year ago · +258.2% on the quarter before
Earnings per share
₹1.03+415.0% on a year ago · +267.9% on the quarter before
Operating margin
14.5%
Net margin
9.9%

From revenue to net profit, ₹ crore

  1. Revenue570
  2. Materials and goods−319
  3. Employee costs−62
  4. Other expenses−106
  5. Operating profit83
  6. Depreciation−8.3
  7. Other income+5.2
  8. Finance costs−4.8
  9. Profit before tax75
  10. Tax−18
  11. Joint ventures+0.1
  12. Net profit56

Morepen Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 12 NovDec 2021Q3Filed 9 FebMar 2022Q4Filed 6 MayJun 2022Q1Filed 30 JulSep 2022Q2Filed 11 NovDec 2022Q3Filed 13 FebMar 2023Q4Filed 17 MayJun 2023Q1Filed 5 AugSep 2023Q2Filed 3 NovDec 2023Q3Filed 1 FebMar 2024Q4Filed 22 MayJun 2024Q1Filed 13 AugSep 2024Q2Filed 11 NovDec 2024Q3Filed 6 FebMar 2025Q4Filed 10 JunJun 2025Q1Filed 6 AugSep 2025Q2Filed 14 NovDec 2025Q3Filed 10 FebMar 2026Q4Filed 26 MayJun 2026Q1Filed 4 Aug
Revenue from operations395396368302403348364401422445423455438453466425412484485570
353364350288374328348375388394375404394417424401381438460488
Materials and goods bought273266241209275231240261273272257283270291316262264297300319
Employee costs3940463639384243434748485054575557625962
Other expenses415862436060657072757073747251836078102106
Operating profit before depreciation4232191529211626345148524436422431462483
Operating margin10.6%8.1%5.1%4.8%7.2%5.9%4.3%6.5%8.0%11.4%11.4%11.3%10.1%8.0%9.1%5.7%7.5%9.6%5.0%14.5%
Depreciation and amortisation777777788810625169111068
Other income33311132344355545485
Finance costs−91100110021111544445
Profit before one-off items and tax472714822141121294442484635261620352375
One-off items000000000000000026000
Profit before tax472714822141121294442484635261646352375
9623653671213121195458818
Tax rate20.3%20.7%13.1%32.2%29.1%35.8%26.0%28.7%25.9%27.3%31.9%24.9%24.3%24.2%21.0%26.5%10.2%22.4%32.6%24.4%
Share of profit of joint ventures and associates00000000000–––0−10000
Net profit3722126169815213228363527201141281656
Other comprehensive income−1001−10−11−10−23−10−11−1160
Total comprehensive income3722126159716203226393426201140282257
Net margin9.5%5.4%3.3%1.9%3.9%2.6%2.3%3.6%5.0%7.2%6.7%7.9%8.0%5.9%4.4%2.5%9.9%5.7%3.2%9.9%
Net margin without joint ventures and associates9.5%5.4%3.3%1.9%3.9%2.6%2.3%3.6%5.0%7.2%6.8%–––4.4%2.7%10.0%5.7%3.2%9.9%
Earnings per share₹0.83₹0.48₹0.27₹0.12₹0.33₹0.15₹0.16₹0.29₹0.42₹0.63₹0.54₹0.71₹0.65₹0.49₹0.35₹0.20₹0.75₹0.50₹0.28₹1.03
Diluted earnings per share₹0.72₹0.41₹0.24₹0.11₹0.33–₹0.16₹0.29₹0.42₹0.63₹0.54₹0.71₹0.65₹0.49₹0.35₹0.20₹0.75₹0.50₹0.28₹1.03
Earnings per share in rupees, restated for later splits and bonuses.

Filed results, as an XML file each

16 earlier filings